Stock DNTH DIANTHUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Dianthus Therapeutics, Inc.

Equities

DNTH

US2528281080

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
21.77 USD -5.55% Intraday chart for Dianthus Therapeutics, Inc. -11.40% +109.33%
May. 16 HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target MT
May. 10 Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. DNTH Stock
  4. Revisions Dianthus Therapeutics, Inc.